Gannet BioChem
Manufacturing · Alabama, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1112 Church St NW, Huntsville, Alabama, ...Phone Number
(256) 512-9200Website
www.gannetbiochem.comRevenue
$46.6 MillionIndustry
About Gannet BioChem
Gannet BioChem Org Chart
Is Gannet BioChem your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Gannet BioChem had a recent Job posting/layoffs
Earning: See what the market has to say on Gannet BioChem recently announced quarterly report
Gannet BioChem, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Gannet BioChem has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Gannet BioChem
Funding: Get notified immidiatlly once Gannet BioChem has new funding data
Product Launch: Get notified when Gannet BioChem launches new products
Check out if Gannet BioChem is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Gannet BioChem as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Gannet BioChem is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gannet BioChem is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gannet BioChem.
Gannet BioChem Tech Stack
A closer look at the technologies used by Gannet BioChem
Gannet BioChem News & Media
Gannet BioChem Acquires Laysan Bio to Expand Activated Polymer and Bioconjugation Capabilities
Huntsville, AL, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Huntsville, AL – Gannet BioChem, a leading specialty Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today announced the acquisition of Laysan Bio, a life sciences company based in Arab, Alabama. The acquisition strengthens Gannet BioChem’s capabilities across activated polymer technologies, including PEG reagents and bioconjugation while enhancing its ability to suGannet BioChem to Participate in Biotech Showcase 2025
Gannet BioChem to attend Biotech Showcase 2025 and JPM Week, highlighting PEG reagents, polymer conjugation, and GMP manufacturing expertise.Gannet BioChem Achieves Science Based Targets initiative (SBTi) Validation for Near-Term Climate Commitments
Huntsville, AL, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity firm Ampersand Capital Partners, today announced that the Science Based Targets initiative (SBTi) has validated the company’s near-term greenhouse gas (GHG) emissions reduction targets. This approval marks an important milestone in the company’s sustainability journey and reinforces its commitment to responLife Sciences Innovator Dr. Art Tipton Joins Gannet BioChem Board
Company to Attend PODD 2025 Company to Attend PODD 2025
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gannet BioChem
Gannet BioChem leverages more than 30 years of history as a leader in polyethylene glycol (PEG) reagents. Our founders were some of the first to identify the potential of PEGylation to unlock performance in small molecule and biologic drugs through bioavailability enhancement, reduced immunogenicity, optimized pharmacokinetics, and improved stabili... Read More